![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Florida Drugmaker Warned for Repeat Violations
Florida Drugmaker Warned for Repeat Violations
August 27, 2019
The FDA hit TG United’s drug manufacturing facility north of Tampa, Florida with a warning letter for repeat water system and cleaning failures found during a lengthy inspection.
The agency inspected the Brooksville facility from Dec. 17, 2018 to Feb. 15, 2019 and cited the firm for investigations of out-of-specification results and water system monitoring failures.
The facility continued manufacturing operations while multiple investigations stability, finished product and raw material testing results were incomplete — a repeat violation from a 2017 agency inspection.
Upcoming Events
-
21Oct